EU | EMA and HMA Consult on Data Standards Framework — Formalising How the Regulatory Network Manages Data Standards
Please login to view this page.
EU | European Medicines Regulatory Network Identifies AI Research Priorities — Reliability, Data Governance and Bias Lead the Agenda
Please login to view this page.
EU | EMA Consults on Qualification of Multinational MS Registry Network for Post-Authorisation Safety Studies
Please login to view this page.
EU | Article 50 AI Transparency Requirements Now Apply — Human Review Exception Important for RWR Publications
Please login to view this page.
EU | Digital Omnibus Resets High-Risk AI Timelines and Expands Rules for Bias and Real-World Testing
Please login to view this page.
EU | Pharmaceutical Reform Enters Legal-Linguistic Finalisation — EMA Establishes Implementation Governance and Begins Stakeholder Engagement
Please login to view this page.
EU | HTACG Sets AI Transparency Expectations for JCA Dossiers — Human Oversight, Tool Disclosure and Prompt Records Required
Please login to view this page.
EU | EMA Steps Up Women’s Health Initiative — Evidence Gaps, Pregnancy Data and RWE Move Higher on the Regulatory Agenda
Please login to view this page.
EU | Two Joint Clinical Assessments Discontinued After Dossiers Fail HTAR Requirements — Evidence Completeness, PICO Coverage and Reproducibility Become Critical GalleryEU | Two Joint Clinical Assessments Discontinued After Dossiers Fail HTAR Requirements — Evidence Completeness, PICO Coverage and Reproducibility Become Critical
EU | Two Joint Clinical Assessments Discontinued After Dossiers Fail HTAR Requirements — Evidence Completeness, PICO Coverage and Reproducibility Become Critical
Please login to view this page.








